益髓颗粒剂改善骨髓巨核系病态造血的临床研究  

Clinical Study on the Effects of Yisui Granules on Improving the Criteria of Dysmegakaryocytopoiesis

作　　者：陈信义[1] 肖萍[1] 胡凯文[1] 王磊[1] 左明焕[1] 孙韬[1] 侯丽[1] 李冬云[1] 韦云[1] 苏伟[1] 

机构地区：[1]北京中医药大学附属东直门医院,北京100700

出　　处：《北京中医药大学学报》1998年第1期44-47,共4页Journal of Beijing University of Traditional Chinese Medicine

基　　金：国家自然科学基金资助项目! ( 3 94 70 863 )

摘　　要：以骨髓巨核系病态造血性疾病MDS患者为研究对象 ,采用益髓颗粒剂为治疗药物。通过临床观察表明 ,在明显改善患者临床主症与出血症状的同时 ,能明显升高患者外周血小板计数 ,并对血红蛋白也有不同程度的提升作用。近期临床显效率 5 5 88% ,总有效率 80 88%。与对照组比较 ,P<0 0 1,差异有显著性。Patients with dysmegakaryocytopoiesis were treated with Yisui Granules (YG). The results showed that besides obviously relieving the patients' main clinical symptoms and hemorrhage, YG could significantly increase peripheral platelet count and raise hemoglobin content to a certain degree. The short_term marked effective rate was 55 88% and the overall effective rate was 80 88% ( P <0 01).

关 键 词：益髓颗粒剂 骨髓增生异常 综合征 中医药疗法 

分 类 号：R551.305[医药卫生—血液循环系统疾病] R286.3[医药卫生—内科学]